Yahoo Search Búsqueda web

Resultado de búsqueda

  1. 27 de jun. de 2024 · Check out STORM CEO, Jerry McMahon, in the latest edition of Optimum TV where he discusses STORM's approach to cellular reprogramming through RNA modification. Jerry highlights the founding of STORM Therapeutics, its technology and lead product STC-15, and more.

  2. Hace 18 horas · About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features NFL Sunday Ticket Press Copyright ...

  3. 27 de jun. de 2024 · Watch Jerry McMahon, CEO of STORM Therapeutics, speaking in Optimum Strategic Communications’ latest edition of Optimum TV where he discusses the Company’s approach to cellular reprogramming through RNA modification and why STORM is leading the field in this area.

  4. 17 de jun. de 2024 · STORM Therapeutics (STORM) a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RME) for oncology and other diseases.

  5. Hace 5 días · By Jerry Capeci. Budding Actor Gives It Up To Join The Mob; But His Old TV Show, Gravesend, Makes It Big.

  6. 28 de jun. de 2024 · Our Q1 2024 earnings report. Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023.

  7. 26 de jun. de 2024 · Jerry McMahon, CEO of STORM, lauded Kouzarides' achievements, noting his unwavering commitment to advancing cellular reprogramming through RNA modification.